{"transactions":[{"id":689729,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":1324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F8","text":"These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027."}],"balance_after":1324,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1324},"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":689728,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":1732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These restricted share units were granted on May 22, 2025 and vested on August 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These restricted share units were granted on May 22, 2025 and vested on August 10, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1732},"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":689727,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":73,"price":165.51,"value":12082.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4."}],"balance_after":3515,"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":689726,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":642,"price":164.47,"value":105589.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4."}],"balance_after":3588,"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":689725,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":105,"price":163.77,"value":17195.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4."}],"balance_after":4230,"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":689724,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":95,"price":162.72,"value":15458.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4."}],"balance_after":4335,"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":689723,"issuer":{"id":3439,"kind":"organization","name":"ICON PLC","symbol":"ICLR"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-12T21:01:57.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":1732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted share units were granted on May 22, 2025 and vested on August 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting."}],"balance_after":4430,"source":{"system":"sec-edgar","filing":"0001628280-26-056327","document":"wk-form4_1786568513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060955/000162828026056327/wk-form4_1786568513.xml","form_type":"4"}},{"id":1474576,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T20:15:21.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award shall vest and become fully exercisable on the earlier to occur of (a) June 17, 2025 and (b) the date of the Issuer's next annual meeting of its stockholders."}],"balance_after":49000,"derivative":{"exercise_price":0.71,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001415889-24-017387","document":"form4-06182024_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000141588924017387/form4-06182024_040609.xml","form_type":"4"}},{"id":1860020,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:15:40.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier to occur of (a) June 9, 2024 and (b) the date of the Issuer's 2024 annual meeting of its stockholders."}],"balance_after":26000,"derivative":{"exercise_price":1.01,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001104659-23-070002","document":"tm2318326-4_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465923070002/tm2318326-4_4seq.xml","form_type":"4"}},{"id":2216720,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T20:12:29.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 30, 2023."}],"balance_after":20000,"derivative":{"exercise_price":1.63,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-076830","document":"tm2220275-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465922076830/tm2220275-8_4seq1.xml","form_type":"4"}},{"id":2680413,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T00:36:28.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 1, 2022."}],"balance_after":9600,"derivative":{"exercise_price":16.61,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-21-077248","document":"tm2118388d4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465921077248/tm2118388d4_4seq1.xml","form_type":"4"}},{"id":3000412,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T20:03:34.000Z","date":"2020-10-21","kind":"grant","acquired":true,"shares":4969,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4969,"source":{"system":"sec-edgar","filing":"0001104659-20-117708","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465920117708/a4.xml","form_type":"4"}},{"id":3103887,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:27:49.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 18, 2021."}],"balance_after":9600,"derivative":{"exercise_price":11.45,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-20-075253","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465920075253/a4.xml","form_type":"4"}},{"id":3321372,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T21:04:19.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on December 18, 2020."}],"balance_after":9600,"derivative":{"exercise_price":9.96,"expiration_date":"2029-12-18","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-20-000852","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465920000852/a4.xml","form_type":"4"}},{"id":3549848,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-24T21:33:16.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":6924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 8 equal quarterly installments thereafter."}],"balance_after":6924,"derivative":{"exercise_price":14,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":6924},"source":{"system":"sec-edgar","filing":"0001104659-19-023454","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630299/000110465919023454/a4.xml","form_type":"4"}},{"id":4021785,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-02T16:59:44.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":8940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":51727,"source":{"system":"sec-edgar","filing":"0000899866-18-000057","document":"wf-form4_152002796986423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000057/wf-form4_152002796986423.xml","form_type":"4"}},{"id":4025208,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-01T17:25:21.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":686,"price":118.61,"value":81366.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":42787,"source":{"system":"sec-edgar","filing":"0000899866-18-000048","document":"wf-form4_151994310701630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000048/wf-form4_151994310701630.xml","form_type":"4"}},{"id":4025207,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-01T17:25:21.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":939,"price":120.72,"value":113356.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":43473,"source":{"system":"sec-edgar","filing":"0000899866-18-000048","document":"wf-form4_151994310701630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000048/wf-form4_151994310701630.xml","form_type":"4"}},{"id":4071043,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:41.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":4787,"price":116.31,"value":556775.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":44412,"source":{"system":"sec-edgar","filing":"0000899866-18-000038","document":"wf-form4_151813538670414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000038/wf-form4_151813538670414.xml","form_type":"4"}},{"id":4071042,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:41.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 7,500 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/4 of such shares vested on February 6, 2018 and 1/4 vest on each subsequent anniversary."}],"balance_after":49199,"source":{"system":"sec-edgar","filing":"0000899866-18-000038","document":"wf-form4_151813538670414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000038/wf-form4_151813538670414.xml","form_type":"4"}},{"id":4071041,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:41.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":21489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 21,489 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary."}],"balance_after":41699,"source":{"system":"sec-edgar","filing":"0000899866-18-000038","document":"wf-form4_151813538670414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000038/wf-form4_151813538670414.xml","form_type":"4"}},{"id":4072802,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-07T18:35:27.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":2119,"price":117.26,"value":248473.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":20210,"source":{"system":"sec-edgar","filing":"0000899866-18-000014","document":"wf-form4_151804651266221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000014/wf-form4_151804651266221.xml","form_type":"4"}},{"id":4218671,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-09-05T19:28:16.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":650,"price":145.81,"value":94776.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":22329,"source":{"system":"sec-edgar","filing":"0000899866-17-000161","document":"wf-form4_150465408293648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000161/wf-form4_150465408293648.xml","form_type":"4"}},{"id":4218670,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-09-05T19:28:16.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":600,"price":145.64,"value":87384.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $145.51 - $146.51.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":22979,"source":{"system":"sec-edgar","filing":"0000899866-17-000161","document":"wf-form4_150465408293648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000161/wf-form4_150465408293648.xml","form_type":"4"}},{"id":4218669,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-09-05T19:28:16.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":672,"price":147,"value":98784.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":23579,"source":{"system":"sec-edgar","filing":"0000899866-17-000161","document":"wf-form4_150465408293648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000161/wf-form4_150465408293648.xml","form_type":"4"}},{"id":4218668,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-09-05T19:28:16.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":1841,"price":145.81,"value":268436.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":24251,"source":{"system":"sec-edgar","filing":"0000899866-17-000161","document":"wf-form4_150465408293648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000161/wf-form4_150465408293648.xml","form_type":"4"}},{"id":4218667,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-09-05T19:28:16.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":612,"price":142,"value":86904.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $142.00 - $142.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":26092,"source":{"system":"sec-edgar","filing":"0000899866-17-000161","document":"wf-form4_150465408293648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000161/wf-form4_150465408293648.xml","form_type":"4"}},{"id":4222027,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-08-30T18:13:11.000Z","date":"2017-08-28","kind":"sale","acquired":false,"shares":11160,"price":140,"value":1562400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":26704,"source":{"system":"sec-edgar","filing":"0000899866-17-000157","document":"wf-form4_150413117771204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000157/wf-form4_150413117771204.xml","form_type":"4"}},{"id":4401333,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-06T18:03:29.000Z","date":"2017-03-02","kind":"sale","acquired":false,"shares":651,"price":133.8,"value":87103.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.00 - $133.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":37864,"source":{"system":"sec-edgar","filing":"0000899866-17-000066","document":"wf-form4_148884139522721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000066/wf-form4_148884139522721.xml","form_type":"4"}},{"id":4415435,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-01T19:46:03.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":14800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Stock option award under 2004 Incentive Plan.  25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years."}],"balance_after":14800,"derivative":{"exercise_price":131.25,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, par value $.0001 per share","underlying_shares":14800},"source":{"system":"sec-edgar","filing":"0000899866-17-000059","document":"wf-form4_148841554965881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000059/wf-form4_148841554965881.xml","form_type":"4"}},{"id":4415434,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:46:03.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Award of Restricted Stock Units under the 2004 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":38515,"source":{"system":"sec-edgar","filing":"0000899866-17-000059","document":"wf-form4_148841554965881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000059/wf-form4_148841554965881.xml","form_type":"4"}},{"id":4415433,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:46:03.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":664,"price":131.7,"value":87448.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":31015,"source":{"system":"sec-edgar","filing":"0000899866-17-000059","document":"wf-form4_148841554965881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000059/wf-form4_148841554965881.xml","form_type":"4"}},{"id":4415432,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:46:03.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":910,"price":131.2,"value":119392.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":31679,"source":{"system":"sec-edgar","filing":"0000899866-17-000059","document":"wf-form4_148841554965881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000059/wf-form4_148841554965881.xml","form_type":"4"}},{"id":4462480,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":24299,"kind":"person","name":"O'Neill Julie","position":1,"cik":"0001630299","reported_name":"O'Neill Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP. Global Operations"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-02-08T16:40:37.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":2795,"price":125.69,"value":351303.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $125.00 - $125.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":32589,"source":{"system":"sec-edgar","filing":"0000899866-17-000030","document":"wf-form4_148659002434774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000030/wf-form4_148659002434774.xml","form_type":"4"}}]}